SCHEMBL10929004

SCHEMBL10929004

O=C1CCSC(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
CASP1 P29466 1/20 0.56
CYP2C19 P33261 1/20 0.56
RECQL P46063 1/20 0.56
SLC8B1 Q6J4K2 1/20 0.56
ALDH1A1 P00352 1/20 0.51
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
ADRA1A P35348 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10929981 0.84 MAPT (0.77) MAPTTP53CYP1A2CYP2C9ALOX15
SCHEMBL11079648 0.77 ALDH1A1 (0.50) MAPTTP53CYP1A2CYP2C9ALOX15
SCHEMBL869274 0.72 TP53 (1.00) MAPTTP53CYP1A2CYP2C9ALOX15
SCHEMBL31071906 0.72 TP53 (1.00) MAPTTP53CYP1A2CYP2C9ALOX15
SCHEMBL11080868 0.72 MAPT (0.50) MAPTTP53CYP1A2CYP2C9ALOX15
SCHEMBL10353386 0.69 SNCA (0.52) MAPTLMNAMEN1KMT2AHPGD
SCHEMBL1347263 0.69 CRBN (0.46) MAPTALDH1A1LMNAGAAKMT2A
SCHEMBL29576353 0.68 ALDH1A1 (0.46) MAPTALDH1A1GABRPGABRDGABRA1
SCHEMBL27729482 0.67 TP53 (0.47) MAPTTP53CYP1A2CYP2C9ALOX15
SCHEMBL7713388 0.66 HSD17B10 (0.53) MAPTALDH1A1LMNAKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0072029-B1 TRIAZOLOBENZAZEPINES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-10-22 EP disclosed
US-4464300-A PSYCHOTROPIC, ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1984-08-07 US disclosed
EP-0072029-A2 Triazolobenzazepines, process and intermediates for their preparation and medicines containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-02-16 EP disclosed